Microplastic accumulation in fibrotic intestinal tissue and mesenteric adipose tissue in Crohn's disease patients

Fengfei Wu1, Fangting Wu1, Xi Liu1

  • 1Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Environmental Research
|February 13, 2025
PubMed

Insights

Microplastics (MPs) accumulate in the fibrotic intestines of Crohn's disease (CD) patients, with higher concentrations linked to increased intestinal fibrosis. Invasive procedures may worsen MP accumulation in the gut.

Area of Science:

  • Gastroenterology
  • Environmental Health
  • Materials Science

Background:

  • Crohn's disease (CD) patients are susceptible to environmental factors.
  • The role of microplastics (MPs) in CD pathogenesis is unknown.
  • MPs are ubiquitous environmental pollutants with potential health impacts.

Purpose of the Study:

  • To investigate the presence and characteristics of microplastics (MPs) in the intestinal tissue and mesenteric adipose tissue of Crohn's disease (CD) patients.
  • To determine the correlation between MP contamination and the severity of intestinal fibrosis in CD.
  • To explore potential sources and mechanisms of MP accumulation in the CD gut.

Main Methods:

  • Analysis of paired involved and uninvolved ileal segments and adjacent mesenteric adipose tissue from CD patients.
  • Identification and quantification of MPs using laser infrared imaging spectrometry and laser direct infrared spectroscopy.
  • Correlation analysis between MP concentrations, MP size distribution, and the degree of intestinal fibrosis.

Main Results:

  • Widespread contamination by 12 types of MPs (e.g., Chlorinated polyethylene, Acrylate copolymer) was detected in CD patient tissues.
  • MP concentrations positively correlated with the severity of intestinal fibrosis.
  • Frequent invasive gastrointestinal examinations were identified as a potential factor exacerbating MP accumulation in fibrotic intestines.

Conclusions:

  • This study provides the first evidence of significant microplastic contamination in the fibrotic intestines and associated adipose tissue of Crohn's disease patients.
  • Microplastics may penetrate the epithelial barrier and contribute to the exacerbation of intestinal fibrosis and creeping fat in CD.
  • Further research is needed to elucidate the precise mechanisms by which MPs influence CD progression.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
171
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
64
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
384
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
304